skip to Main Content
Get your free newsletter: Actionable insight each morning for self-directed investors. 
Home » UK Shares » AIM Risers and Fallers » AIM round-up: Abingdon Health, Poolbeg Pharma, Online Blockchain

London’s AIM Index has ground out some modest gains through the session, finishing the day just over three points higher at 1265.97

  • Abingdon Health +109%
  • Poolbeg Pharma +23%
  • Helium One Global -15%
  • Real Good Food -14%
  • Online Blockchain +11%

Abingdon Health [LON:ABDX] surged 109% as the week got underway, with investors digesting this morning’s news that the company has launched a self-testing kit which looks for the presence of COIVD-19 antibodies. This coincides with a government initiative to provide antibody tests for those who test positive for COVID-19 via PCR so is clearly of the moment. On the basis that COVID remains transmissible even amongst the double vaccinated, there’s evident optimism that this stock could soon find its way back the IPO level.

Subscribe for more stories like this, 8am weekdays - for free!

Poolbeg Pharma [LON:POLB] was another biotech firm to see a good start to the week. There’s no official news out but the company received an encouraging write up in the weekend media, highlighting the prospects of its work in treating infectious diseases.

Helium One Global [LON:HE1]] ended up at the bottom of the board, slipping 15% reversing some of those gains from the end of last week which were realised off the back of an encouraging drilling statement. Volumes remain inflated and the stock continues to sit in the shadow of the losses posted earlier in the month, suggesting profit takers have won out despite the hoped for long term prospects.

Real Good Food [LON:RGD] also slipped 14% by the bell. There’s no to attribute to the news but this is a £2m company and the fall is barely outside the spread.

A notable mention for Online Blockchain [LON:OBC] which added 11% across the day. Bitcoin tested the $50k mark for the first time since May and this appears to be driving sentiment behind the stock. For UK retail investors prevented from investing directly in BTC this certainly appears to offer some proxy value.

This article is not investment advice. Investors should do their own research or consult a professional advisor.

Tony Cross

Tony Cross

Tony Cross is a market commentator with over 15 years of experience, producing compelling, insightful copy for journalists and investors alike. Focusing on macroeconomics, UK blue chip equities and inter market analysis, Cross's commentary is well regarded for its clarity and ability to cut through the waffle. He has been quoted in publications as diverse as The Financial Times, The Times, The Guardian and The Sun. He has also been a regular guest on both Share Radio and TipTV.

Stocks in Focus

Here are some of the smaller companies we follow most closely. They represent significant growth stories in our view. Our in-depth reports detail why we like them.


Subscribe for more stories like this, 8am weekdays - for free!

Get your free daily newsletter: 

Thanks to our Partners

Our partners are established, regulated businesses and we are grateful for their support.

FP Markets
Back To Top